MarkHowardDuncanMD

PubMed

• Project ECHO in Psychiatric Workforce Development: the Example of a Perinatal Mental Health ECHO.
  Ramaraj, A., Franz, N., Adachi, J., Quiray, J., Bhat, A., Bespalova, N., Duncan, M., Cowley, D.> ;Academic Psychiatry. 2023 Dec 12
• Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?
  John C Fortney, Anna D Ratzliff, Brittany E Blanchard, Morgan Johnson, Lori Ferro, Elizabeth J Austin, Emily C Williams, Mark H Duncan, Jennifer Thomas, Brandon Kitay,...> ;Annals of Internal Medicine. 2023 Oct 1
• Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-...
  Kevin A Hallgren, Mark H Duncan, Matthew D Iles-Shih, Eliza B Cohn, Connor J McCabe, Yanni M Chang, Andrew J Saxon> ;JMIR Formative Research. 2023 Jul 6
• 3 citations
  Psychiatry's Expanded Integration into Primary Care.
  Mark H Duncan, Jennifer M Erickson, Denise Chang, Ramanpreet Toor, Anna D H Ratzliff> ;The Psychiatric Clinics of North America. 2022 Mar 1
• Development and Implementation of an Integrated Care Fellowship.
  Anna D H Ratzliff, Ramanpreet Toor, Jennifer M Erickson, Amy M Bauer, Mark H Duncan, Denise Chang, Lydia Chwastiak, Patrick J Raue, Jurgen Unutzer> ;Journal of the Academy of Consultation-Liaison Psychiatry. 2022 Feb 3
• 6 citations
  Dual study describing patient-driven harm reduction goal-setting among people experiencing homelessness and alcohol use disorder.
  Taurmini Fentress, Sazi Wald, Aaron Brah, Griffin Leemon, Rosemary Reyes, Fatma Alkhamees, Madeline Kramer, Emily M. Taylor, Megan Wildhood, Tessa Frohe, Mark H. Dunca...> ;Experimental and Clinical Psychopharmacology. 2021 Jun 1
• 11 citations
  Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised cl...
  Susan E. Collins, Mark H. Duncan, Andrew J. Saxon, Emily M. Taylor, Nigel Mayberry, Joseph O. Merrill, Gail Hoffmann, Seema L. Clifasefi, Richard K. Ries> ;The Lancet. Psychiatry. 2021 Apr 1
• The Next Stage of Buprenorphine Care for Opioid Use Disorder.
  Mark H. Duncan, Anna Ratzliff, Diane Powers, Caleb J. Banta-Green, Andrew J. Saxon> ;Annals of Internal Medicine. 2019 Jun 4
• 20 citations
  Leveraging Behavioral Health Expertise: Practices and Potential of the Project ECHO Approach to Virtually Integrating Care in Underserved Areas
  Brant Hager, Michael J. Hasselberg, Eric Arzubi, Jonathan Betlinski, Mark Duncan, Jennifer H. Richman, Lori E. Raney> ;Psychiatric Services. 2018 Feb 15
• 25 citations
  Extended-Release Naltrexone and Harm Reduction Counseling for Chronically Homeless People With Alcohol Dependence
  Susan E. Collins, Mark H. Duncan, Brian F. Smart, Andrew J. Saxon, Daniel K. Malone, T. Ron Jackson, Richard K. Ries> ;Substance Abuse. 2015 Jan 22
• 1 citations
  Addiction disorders.
  Joseph O Merrill, Mark H Duncan> ;The Medical Clinics of North America. 2014 Sep 1
• 8 citations
  Harm reduction with pharmacotherapy for homeless people with alcohol dependence: Protocol for a randomized controlled trial
  Susan E. Collins, Andrew J. Saxon, Mark H. Duncan, Brian F. Smart, Joseph O. Merrill, Daniel K. Malone, T. Ron Jackson, Seema L. Clifasefi, Jutta M. Joesch, Richard K....> ;Contemporary Clinical Trials. 2014 Jul 1
• Join now to see all